124 related articles for article (PubMed ID: 37890350)
21. Inguinal Sentinel Lymph Node in a Patient With Recurrent Breast Cancer.
Álvarez-Moreno M; Álvarez-Santos J; Manzarbeitia-Arroba B; Balsa-Bretón MÁ; Sandoval-Moreno C
Clin Nucl Med; 2023 Mar; 48(3):e143-e144. PubMed ID: 36723901
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis.
Fan YJ; Li JC; Zhu DM; Zhu HL; Zhao Y; Zhu XB; Wu G; Bai TT
BMC Surg; 2023 Jul; 23(1):209. PubMed ID: 37495945
[TBL] [Abstract][Full Text] [Related]
24. Omission of axillary sentinel lymph node biopsy in early invasive breast cancer.
Reimer T
Breast; 2023 Feb; 67():124-128. PubMed ID: 36658052
[TBL] [Abstract][Full Text] [Related]
25. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
26. Using MammaPrint on core needle biopsy to guide the need for axillary staging during breast surgery.
Drapalik LM; Miller ME; Rock L; Li P; Simpson A; Shenk R; Amin AL
Surgery; 2024 Mar; 175(3):579-586. PubMed ID: 37852835
[TBL] [Abstract][Full Text] [Related]
27. Excision of both pretreatment marked positive nodes and sentinel nodes improves axillary staging after neoadjuvant systemic therapy in breast cancer.
Simons JM; van Pelt MLMA; Marinelli AWKS; Straver ME; Zeillemaker AM; Pereira Arias-Bouda LM; van Nijnatten TJA; Koppert LB; Hunt KK; Smidt ML; Luiten EJT; van der Pol CC
Br J Surg; 2019 Nov; 106(12):1632-1639. PubMed ID: 31593294
[TBL] [Abstract][Full Text] [Related]
28. Sentinel Lymph Node Positive Rate Predicts Non-Sentinel Lymph Node Metastasis in Breast Cancer.
Wang X; Zhang G; Zuo Z; Zhu Q; Wu S; Zhou Y; Mao F; Lin Y; Shen S; Zhang X; Qin X; Yan C; Ma X; Shi Y; Sun Q
J Surg Res; 2022 Mar; 271():59-66. PubMed ID: 34839110
[TBL] [Abstract][Full Text] [Related]
29. Independent risk factors for axillary lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes.
Zhang W; Xu J; Wang K; Tang XJ; Liang H; He JJ
BMC Womens Health; 2020 Jul; 20(1):143. PubMed ID: 32646416
[TBL] [Abstract][Full Text] [Related]
30. Prediction score model for non-sentinel and four or more nodal metastases using a combined method of one-step nucleic acid amplification and histology in sentinel node-positive breast cancer patients.
Jimbo K; Kinoshita T; Ogura T; Watase C; Murata T; Shiino S; Takayama S; Yoshida M
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):516-521. PubMed ID: 31711717
[TBL] [Abstract][Full Text] [Related]
31. Determinants for non-sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 602 consecutive patients with sentinel node metastases.
Majid S; Rydén L; Manjer J
BMC Cancer; 2019 Jun; 19(1):626. PubMed ID: 31238899
[TBL] [Abstract][Full Text] [Related]
32. Risk factors of non-sentinel lymph node metastasis in 443 breast cancer patients with sentinel lymph node-positive.
Cai SL; Wei RM; Han L; Chen XG; Gong GX; Lin XQ; Zhang J; Chen HD
Medicine (Baltimore); 2022 Jul; 101(29):e29286. PubMed ID: 35866760
[TBL] [Abstract][Full Text] [Related]
33. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?
Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH
Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791
[TBL] [Abstract][Full Text] [Related]
34. Contrast-enhanced lymphatic US can improve the preoperative diagnostic performance for sentinel lymph nodes in early breast cancer.
Niu Z; Gao Y; Xiao M; Mao F; Zhou Y; Zhu Q; Jiang Y
Eur Radiol; 2023 Mar; 33(3):1593-1602. PubMed ID: 36152038
[TBL] [Abstract][Full Text] [Related]
35. A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted Axillary Lymph Node Dissection Who Need Abemaciclib Therapy.
Yang H; Sun Y; Wang P; Qiao J; Li L; Lu Z; Sun X; Zhang C; Chen X; Yan M; Cui S; Wang C; Liu Z
Med Sci Monit; 2023 Jul; 29():e940124. PubMed ID: 37454245
[TBL] [Abstract][Full Text] [Related]
36. Deep learning approach to predict sentinel lymph node status directly from routine histology of primary melanoma tumours.
Brinker TJ; Kiehl L; Schmitt M; Jutzi TB; Krieghoff-Henning EI; Krahl D; Kutzner H; Gholam P; Haferkamp S; Klode J; Schadendorf D; Hekler A; Fröhling S; Kather JN; Haggenmüller S; von Kalle C; Heppt M; Hilke F; Ghoreschi K; Tiemann M; Wehkamp U; Hauschild A; Weichenthal M; Utikal JS
Eur J Cancer; 2021 Sep; 154():227-234. PubMed ID: 34298373
[TBL] [Abstract][Full Text] [Related]
37. Our house believes that: The clipped lymph node is the true sentinel node after neoadjuvant chemotherapy in N+ patients.
Acea-Nebril B; García-Novoa A; Bouzón Alejandro A; Díaz Carballada C; Conde Iglesias C
Breast; 2023 Dec; 72():103592. PubMed ID: 37857128
[TBL] [Abstract][Full Text] [Related]
38. A machine-learning approach based on multiparametric MRI to identify the risk of non-sentinel lymph node metastasis in patients with early-stage breast cancer.
Yu H; Li Q; Xie F; Wu S; Chen Y; Huang C; Xu Y; Niu Q
Acta Radiol; 2024 Feb; 65(2):185-194. PubMed ID: 38115683
[TBL] [Abstract][Full Text] [Related]
39. Is it always necessary to perform an axillary lymph node dissection after neoadjuvant chemotherapy for breast cancer?
Osorio-Silla I; Gómez Valdazo A; Sánchez Méndez JI; York E; Díaz-Almirón M; Gómez Ramírez J; Rivas Fidalgo S; Oliver JM; Álvarez CM; Hardisson D; Díaz Miguel M; Lobo F; Díaz Domínguez J
Ann R Coll Surg Engl; 2019 Mar; 101(3):186-192. PubMed ID: 30421628
[TBL] [Abstract][Full Text] [Related]
40. Lymph Node Metastasis Prediction from Primary Breast Cancer US Images Using Deep Learning.
Zhou LQ; Wu XL; Huang SY; Wu GG; Ye HR; Wei Q; Bao LY; Deng YB; Li XR; Cui XW; Dietrich CF
Radiology; 2020 Jan; 294(1):19-28. PubMed ID: 31746687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
